Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course
Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeu...
Saved in:
Published in | Heliyon Vol. 10; no. 18; p. e37838 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
30.09.2024
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2405-8440 2405-8440 |
DOI | 10.1016/j.heliyon.2024.e37838 |
Cover
Loading…
Abstract | Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies.
Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro.
Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts.
Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts. |
---|---|
AbstractList | Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies.
Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro.
Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts.
Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts. Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts. Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies.Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro.Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts.Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts. Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts. |
ArticleNumber | e37838 |
Author | Kan, Jun-yan Gu, Yue Xu, Ke Wu, Li-da Wang, Dong-chen Jiang, Zi-hao |
Author_xml | – sequence: 1 givenname: Jun-yan orcidid: 0000-0001-6838-8556 surname: Kan fullname: Kan, Jun-yan email: kanjy98@126.com – sequence: 2 givenname: Dong-chen surname: Wang fullname: Wang, Dong-chen email: wdcmed1995@163.com – sequence: 3 givenname: Zi-hao surname: Jiang fullname: Jiang, Zi-hao email: jiangzihao357@163.com – sequence: 4 givenname: Li-da surname: Wu fullname: Wu, Li-da email: lidawunjmu@outlook.com – sequence: 5 givenname: Ke surname: Xu fullname: Xu, Ke email: xukehigh123@stu.njmu.edu.cn – sequence: 6 givenname: Yue surname: Gu fullname: Gu, Yue email: guyue_jessica@163.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39315128$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUk1vEzEUtFARLaE_AeQjlwR_rr1cUBXxEamiCMHZ8tpvE0ebdbB3W-Xf43RDaU9w8pM9bzTjmZforI89IPSakgUltHq3XWygC4fYLxhhYgFcaa6foQsmiJxrIcjZo_kcXea8JYRQqata8RfonNecSsr0BQrfUlwnyDnEHrcp7rCzyYe4O8S9HTYHPES8AZsG3NrQjQnwXRg2OIEfHXgMW3DDtGrvh_f4Ci9vvq--Yg9tcAH6Abs4pgyv0PPWdhkuT-cM_fz08cfyy_z65vNqeXU9d5LKYc4crwC8tYJXtlYNr5Twsm1ULTSnDbha0VZLqnilldXMK68IcU1NWiZ8A3yGVhOvj3Zr9insbDqYaIO5v4hpbYqd4DowmkBV1gVroOx6pV0LvvJt7T2VxLHC9WHi2o_NDrwrbpLtnpA-fenDxqzjraFUUMWK4hl6e2JI8dcIeTC7kB10ne0hjtmUHASVda3Zf0CJVpVUdVWgbx7rehD0J9cCkBPApZhzgvYBQok5VshszalC5lghM1Xor2EoCd0GSCYfMyxRh1SSLl8Y_sHwG6Za028 |
Cites_doi | 10.1038/s41586-022-04817-8 10.1038/s41421-022-00490-3 10.1093/cvr/cvaa023 10.1016/j.peptides.2018.05.012 10.1172/jci.insight.133782 10.1016/j.jacbts.2022.10.010 10.1093/bioinformatics/btm254 10.1111/joim.12944 10.1038/s41598-021-89451-6 10.1056/NEJMoa021332 10.1161/HYPERTENSIONAHA.115.06300 10.1016/j.mayocp.2020.04.028 10.1186/1471-2105-9-559 10.1056/NEJMoa1409077 10.1093/nar/gkv007 10.3390/ijms23020946 10.1016/j.jcmg.2020.11.006 10.1161/CIRCRESAHA.115.306565 10.1093/bioinformatics/bti623 10.1038/nmeth.3337 10.1073/pnas.0506580102 10.1016/j.yjmcc.2019.04.011 10.1038/s41467-021-21246-9 10.1186/1471-2105-11-367 10.1161/HYPERTENSIONAHA.112.193631 10.1136/heartjnl-2021-320729 10.1016/j.yexcr.2021.112552 10.1186/s12916-019-1469-4 10.1016/S0140-6736(21)01205-8 10.1073/pnas.150149097 10.1373/clinchem.2010.143883 10.1016/j.jacbts.2022.03.017 10.1038/s41419-022-05403-6 10.1016/j.pharmthera.2022.108185 10.1042/CS20110403 10.1161/CIRCULATIONAHA.121.056324 10.1161/CIRCRESAHA.118.313089 10.1161/CIRCULATIONAHA.120.050498 10.1161/CIRCHEARTFAILURE.109.895581 10.1085/jgp.202213204 10.1161/CIRCHEARTFAILURE.109.903849 10.1002/ehf2.12288 10.1186/1471-2105-12-77 10.1002/ejhf.1461 10.1001/jama.2020.10262 10.1093/bioinformatics/btx364 10.1038/s41587-021-01033-z 10.1038/s41587-021-01091-3 10.1093/nar/28.1.27 10.1161/CIRCRESAHA.117.309711 10.1016/j.jacc.2022.03.375 10.1161/01.CIR.92.4.785 |
ContentType | Journal Article |
Copyright | 2024 2024 The Authors. Published by Elsevier Ltd. 2024 The Authors. Published by Elsevier Ltd. 2024 |
Copyright_xml | – notice: 2024 – notice: 2024 The Authors. Published by Elsevier Ltd. – notice: 2024 The Authors. Published by Elsevier Ltd. 2024 |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 5PM DOA |
DOI | 10.1016/j.heliyon.2024.e37838 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed AGRICOLA |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2405-8440 |
ExternalDocumentID | oai_doaj_org_article_80e67d742be24dd78cfed6df9dd150c2 PMC11417248 39315128 10_1016_j_heliyon_2024_e37838 S2405844024138698 |
Genre | Journal Article |
GroupedDBID | 0R~ 457 53G 5VS 6I. AAEDW AAFTH AAFWJ AALRI AAYWO ABMAC ACGFS ACLIJ ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPKN AFPUW AFTJW AGHFR AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK EBS FDB GROUPED_DOAJ HYE KQ8 M~E O9- OK1 ROL RPM SSZ AAYXX CITATION EJD IPNFZ RIG 0SF AACTN NCXOZ NPM 7X8 7S9 L.6 5PM |
ID | FETCH-LOGICAL-c515t-2c36eedaa436a97b3674d5fb794831bec971f85173687a82d7d700cb90f24dbe3 |
IEDL.DBID | DOA |
ISSN | 2405-8440 |
IngestDate | Wed Aug 27 01:28:33 EDT 2025 Thu Aug 21 18:30:59 EDT 2025 Fri Aug 22 20:22:16 EDT 2025 Fri Jul 11 02:36:46 EDT 2025 Thu Jan 02 22:37:13 EST 2025 Thu Aug 21 00:27:49 EDT 2025 Sat Aug 30 17:17:39 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 18 |
Keywords | Molecular subtypes Heart failure with reduced ejection fraction Cardiomyopathy Bioinformatics CORIN |
Language | English |
License | This is an open access article under the CC BY-NC license. 2024 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c515t-2c36eedaa436a97b3674d5fb794831bec971f85173687a82d7d700cb90f24dbe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 These authors contributed equally to this work and share first authorship. |
ORCID | 0000-0001-6838-8556 |
OpenAccessLink | https://doaj.org/article/80e67d742be24dd78cfed6df9dd150c2 |
PMID | 39315128 |
PQID | 3108765796 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_80e67d742be24dd78cfed6df9dd150c2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11417248 proquest_miscellaneous_3154159982 proquest_miscellaneous_3108765796 pubmed_primary_39315128 crossref_primary_10_1016_j_heliyon_2024_e37838 elsevier_sciencedirect_doi_10_1016_j_heliyon_2024_e37838 |
PublicationCentury | 2000 |
PublicationDate | 2024-09-30 |
PublicationDateYYYYMMDD | 2024-09-30 |
PublicationDate_xml | – month: 09 year: 2024 text: 2024-09-30 day: 30 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Heliyon |
PublicationTitleAlternate | Heliyon |
PublicationYear | 2024 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Codden, Chin (bib11) 2022; 23 Wang, Ye, Kong, Chao, Yu, Jiang, Luo, Gu, Chen (bib37) 2021; 402 Liu, Yin, Chen, Chen, Li, Zhang, Sun, Yuan, Wang, Song, Wang, Hu, Zhou (bib48) 2023; 9 Sean, Meltzer (bib15) 2007; 23 Murphy, Ibrahim, Januzzi (bib6) 2020; 324 Hahn, Knutsdottir, Luo, Bedi, Margulies, Haldar, Stolina, Yin, Khakoo, Vaishnav, Bader, Kass, Sharma (bib10) 2021; 143 Helms, Tang, O'Leary, Friedline, Wauchope, Arora, Wasserman, Smith, Lee, Wen, Shavit, Liu, Previs, Day (bib14) 2020; 5 Vakrou, Liu, Zhu, Greenland, Simsek, Hebl, Guan, Woldemichael, Talbot, Aon, Fukunaga, Abraham (bib45) 2021; 11 Zou, Ouyang, Lin, Zhang, Yang, Pang, Han, Tang (bib53) 2022; 13 Maron, Gardin, Flack, Gidding, Kurosaki, Bild (bib4) 1995; 92 Ibebuogu, Gladysheva, Houng, Reed (bib59) 2011; 4 Conway, Lex, Gehlenborg (bib26) 2017; 33 Nauffal, Di Achille, Klarqvist, Cunningham, Pirruccello, Weng, Morrill, Choi, Khurshid, Friedman, Nekoui, Roselli, Ng, Philippakis, Batra, Ellinor, Lubitz (bib35) 2021; 55 Sing, Sander, Beerenwinkel, Lengauer (bib28) 2005; 21 Hua, Wang, Jia, Xiong, Hu, Chang, Lai, Xu, Zhao, Song (bib9) 2020; 18 Hua, Wang, Jia, Xiong, Hu, Chang, Lai, Xu, Zhao, Song (bib19) 2020; 18 Nakagawa, Nishikimi, Kuwahara (bib56) 2019; 111 Sun, Guan, Moran, Wu, Qian, Schedin, Dai, Danilov, Alumkal, Adey, Spellman, Xia (bib32) 2022; 40 Ritchie, Phipson, Wu, Hu, Law, Shi, Smyth (bib16) 2015; 43 Jin, Guerrero-Juarez, Zhang, Chang, Ramos, Kuan, Myung, Plikus, Nie (bib33) 2021; 12 McKenna, Maron, Thiene (bib5) 2017; 121 Jassal, Matthews, Viteri, Gong, Lorente, Fabregat, Sidiropoulos, Cook, Gillespie, Haw, Loney, May, Milacic, Rothfels, Sevilla, Shamovsky, Shorser, Varusai, Weiser, Wu, Stein, Hermjakob, D'Eustachio (bib20) 2020; 48 McMurray, Packer, Desai, Gong, Lefkowitz, Rizkala, Rouleau, Shi, Solomon, Swedberg, Zile (bib55) 2014; 371 Gladysheva, Wang, McNamee, Houng, Mohamad, Fan, Reed (bib63) 2013; 61 Schwartz, Gjini, Gopal, Fetterman (bib50) 2022; 7 Wu, Hu, Xu, Chen, Guo, Dai, Feng, Zhou, Tang, Zhan, Fu, Liu, Bo, Yu (bib24) 2021; 2 Newman, Liu, Green, Gentles, Feng, Xu, Hoang, Diehn, Alizadeh (bib30) 2015; 12 Chaffin, Papangeli, Simonson, Akkad, Hill, Arduini, Fleming, Melanson, Hayat, Kost-Alimova, Atwa, Ye, Bedi, Nahrendorf, Kaushik, Stegmann, Margulies, Tucker, Ellinor (bib18) 2022; 608 Bernardi, Burns, Toffoli, Pickering, Sakoda, Tsorotes, Grixti, Velkoska, Burrell, Johnston, Thomas, Fabris, Tikellis (bib46) 2012; 123 Tripathi, Wang, Sullivan, Fan, Gladysheva, Reed (bib60) 2016; 67 Yan, Wu, Morser, Wu (bib57) 2000; 97 Bos, Hebl, Oberg, Sun, Herman, Teekakirikul, Seidman, Seidman, dos Remedios, Maleszewski, V Schaff, Dearani, Noseworthy, Friedman, Ommen, V Brozovich, Ackerman (bib8) 2020; 95 Semenov, Tamm, Seferian, Postnikov, Karpova, Serebryanaya, Koshkina, Krasnoselsky, Katrukha (bib62) 2010; 56 Camici, Tschöpe, Di Carli, Rimoldi, Van Linthout (bib51) 2020; 116 Dann, Henderson, Teichmann, Morgan, Marioni (bib31) 2022; 40 Reichart, Magnussen, Zeller, Blankenberg (bib2) 2019; 286 Maron, Rowin, Casey, Link, Lesser, Chan, Garberich, Udelson, Maron (bib39) 2015 Meng, Bhandary, Bhuiyan, James, Osinska, Valiente-Alandi, Shay-Winkler, Gulick, Molkentin, Blaxall, Robbins (bib54) 2018; 123 Zhang, Gu, Zhang, Dong, Wu (bib61) 2022; 11 Langfelder, Horvath (bib25) 2008; 9 Chaffin, Papangeli, Simonson, Akkad, Hill, Arduini, Fleming, Melanson, Hayat, Kost-Alimova, Atwa, Ye, Bedi, Nahrendorf, Kaushik, Stegmann, Margulies, Tucker, Ellinor (bib12) 2022; 608 Codden, Chin (bib17) 2022; 23 Subramanian, Tamayo, Mootha, Mukherjee, Ebert, Gillette, Paulovich, Pomeroy, Golub, Lander, Mesirov (bib22) 2005; 102 Liang, Raita, Hasegawa, Fifer, Maurer, Reilly, Shimada (bib42) 2022 Kanehisa, Goto (bib23) 2000; 28 Maron, Olivotto, Betocchi, Casey, Lesser, Losi, Cecchi, Maron (bib41) 2003; 348 Tsutsui (bib7) 2022; 238 Bos, Hebl, Oberg, Sun, Herman, Teekakirikul, Seidman, Seidman, dos Remedios, Maleszewski, Schaff, Dearani, Noseworthy, Friedman, Ommen, Brozovich, Ackerman (bib47) 2020; 95 De Lange, Farrell, Hernandez, Stempien, Kreitzer, Jacobs, Petty, Moss, Crone, Ralphe (bib34) 2023; 155 Zuo, Ren, Ge, Luo, Ye, Wang, Wu, Chao, Gu, Gao, Ge, Bin Gao, Hu, Zhang, Chen (bib36) 2019; 130 Hahn, Knutsdottir, Luo, Bedi, Margulies, Haldar, Stolina, Yin, Khakoo, Vaishnav, Bader, Kass, Sharma (bib29) 2021; 143 Ommen, Semsarian (bib1) 2021; 398 Robin, Turck, Hainard, Tiberti, Lisacek, Sanchez, Müller (bib27) 2011; 12 Tayal, Verdonschot, Hazebroek, Howard, Gregson, Newsome, Gulati, Pua, Halliday, Lota, Buchan, Whiffin, Kanapeckaite, Baruah, Jarman, O'Regan, Barton, Ware, Pennell, Adriaans, Bekkers, Donovan, Frenneaux, Cooper, Januzzi, Cleland, Cook, Deo, Heymans, Prasad (bib43) 2022; 79 Mandawat, Chattranukulchai, Mandawat, Blood, Ambati, Hayes, Rehwald, Kim, Heitner, Shah, Klem (bib49) 2021; 14 Dong, Chen, Yang, He, Liu, Zheng, Li, Zhou, Ruan, Plow, Wu (bib58) 2010; 3 Tripathi, Sullivan, Fan, Houng, Mehta, Reed, Gladysheva (bib64) 2020; 21 Seferović, Polovina, Bauersachs, Arad, Ben Gal, Lund, Felix, Arbustini, Caforio, Farmakis, Filippatos, Gialafos, Kanjuh, Krljanac, Limongelli, Linhart, Lyon, Maksimović, Miličić, Milinković, Noutsias, Oto, Oto, Pavlović, Piepoli, Ristić, Rosano, Seggewiss, Ašanin, Seferović, Ruschitzka, Čelutkiene, Jaarsma, Mueller, Moura, Hill, Volterrani, Lopatin, Metra, Backs, Mullens, Chioncel, de Boer, Anker, Rapezzi, Coats, Tschöpe (bib38) 2019; 21 Verdonschot, Wang, Derks, Adriaens, Stroeks, Henkens, Raafs, Sikking, de Koning, van den Wijngaard, Krapels, Nabben, Brunner, Heymans (bib44) 2023; 8 Travers, Kamal, Robbins, Yutzey, Blaxall (bib52) 2016; 118 Gaujoux, Seoighe (bib21) 2010; 11 Kissopoulou, Trinks, Green, Karlsson, Jonasson, Gunnarsson (bib40) 2018; 5 Daniels, Fusi, Semsarian, Naidu (bib3) 2021; 144 De Lange, Farrell, Hernandez, Stempien, Kreitzer, Jacobs, Petty, Moss, Crone, Ralphe (bib13) 2023; 155 Liu (10.1016/j.heliyon.2024.e37838_bib48) 2023; 9 Tripathi (10.1016/j.heliyon.2024.e37838_bib64) 2020; 21 Ritchie (10.1016/j.heliyon.2024.e37838_bib16) 2015; 43 McMurray (10.1016/j.heliyon.2024.e37838_bib55) 2014; 371 Hua (10.1016/j.heliyon.2024.e37838_bib9) 2020; 18 Vakrou (10.1016/j.heliyon.2024.e37838_bib45) 2021; 11 Dann (10.1016/j.heliyon.2024.e37838_bib31) 2022; 40 Robin (10.1016/j.heliyon.2024.e37838_bib27) 2011; 12 Sun (10.1016/j.heliyon.2024.e37838_bib32) 2022; 40 Daniels (10.1016/j.heliyon.2024.e37838_bib3) 2021; 144 Hahn (10.1016/j.heliyon.2024.e37838_bib29) 2021; 143 Bernardi (10.1016/j.heliyon.2024.e37838_bib46) 2012; 123 Nauffal (10.1016/j.heliyon.2024.e37838_bib35) 2021; 55 Reichart (10.1016/j.heliyon.2024.e37838_bib2) 2019; 286 Zhang (10.1016/j.heliyon.2024.e37838_bib61) 2022; 11 Zuo (10.1016/j.heliyon.2024.e37838_bib36) 2019; 130 Tripathi (10.1016/j.heliyon.2024.e37838_bib60) 2016; 67 Newman (10.1016/j.heliyon.2024.e37838_bib30) 2015; 12 Gaujoux (10.1016/j.heliyon.2024.e37838_bib21) 2010; 11 Zou (10.1016/j.heliyon.2024.e37838_bib53) 2022; 13 Verdonschot (10.1016/j.heliyon.2024.e37838_bib44) 2023; 8 Travers (10.1016/j.heliyon.2024.e37838_bib52) 2016; 118 Ibebuogu (10.1016/j.heliyon.2024.e37838_bib59) 2011; 4 Mandawat (10.1016/j.heliyon.2024.e37838_bib49) 2021; 14 De Lange (10.1016/j.heliyon.2024.e37838_bib13) 2023; 155 Tayal (10.1016/j.heliyon.2024.e37838_bib43) 2022; 79 Semenov (10.1016/j.heliyon.2024.e37838_bib62) 2010; 56 Bos (10.1016/j.heliyon.2024.e37838_bib8) 2020; 95 Sean (10.1016/j.heliyon.2024.e37838_bib15) 2007; 23 Nakagawa (10.1016/j.heliyon.2024.e37838_bib56) 2019; 111 Gladysheva (10.1016/j.heliyon.2024.e37838_bib63) 2013; 61 Chaffin (10.1016/j.heliyon.2024.e37838_bib18) 2022; 608 Schwartz (10.1016/j.heliyon.2024.e37838_bib50) 2022; 7 Murphy (10.1016/j.heliyon.2024.e37838_bib6) 2020; 324 Codden (10.1016/j.heliyon.2024.e37838_bib17) 2022; 23 Wu (10.1016/j.heliyon.2024.e37838_bib24) 2021; 2 Maron (10.1016/j.heliyon.2024.e37838_bib41) 2003; 348 Wang (10.1016/j.heliyon.2024.e37838_bib37) 2021; 402 Maron (10.1016/j.heliyon.2024.e37838_bib39) 2015 Camici (10.1016/j.heliyon.2024.e37838_bib51) 2020; 116 Hua (10.1016/j.heliyon.2024.e37838_bib19) 2020; 18 Conway (10.1016/j.heliyon.2024.e37838_bib26) 2017; 33 Jassal (10.1016/j.heliyon.2024.e37838_bib20) 2020; 48 Ommen (10.1016/j.heliyon.2024.e37838_bib1) 2021; 398 Meng (10.1016/j.heliyon.2024.e37838_bib54) 2018; 123 De Lange (10.1016/j.heliyon.2024.e37838_bib34) 2023; 155 Jin (10.1016/j.heliyon.2024.e37838_bib33) 2021; 12 Dong (10.1016/j.heliyon.2024.e37838_bib58) 2010; 3 Langfelder (10.1016/j.heliyon.2024.e37838_bib25) 2008; 9 Seferović (10.1016/j.heliyon.2024.e37838_bib38) 2019; 21 Hahn (10.1016/j.heliyon.2024.e37838_bib10) 2021; 143 Kissopoulou (10.1016/j.heliyon.2024.e37838_bib40) 2018; 5 McKenna (10.1016/j.heliyon.2024.e37838_bib5) 2017; 121 Liang (10.1016/j.heliyon.2024.e37838_bib42) 2022 Helms (10.1016/j.heliyon.2024.e37838_bib14) 2020; 5 Yan (10.1016/j.heliyon.2024.e37838_bib57) 2000; 97 Maron (10.1016/j.heliyon.2024.e37838_bib4) 1995; 92 Codden (10.1016/j.heliyon.2024.e37838_bib11) 2022; 23 Subramanian (10.1016/j.heliyon.2024.e37838_bib22) 2005; 102 Sing (10.1016/j.heliyon.2024.e37838_bib28) 2005; 21 Chaffin (10.1016/j.heliyon.2024.e37838_bib12) 2022; 608 Bos (10.1016/j.heliyon.2024.e37838_bib47) 2020; 95 Tsutsui (10.1016/j.heliyon.2024.e37838_bib7) 2022; 238 Kanehisa (10.1016/j.heliyon.2024.e37838_bib23) 2000; 28 |
References_xml | – volume: 398 start-page: 2102 year: 2021 end-page: 2108 ident: bib1 article-title: Hypertrophic cardiomyopathy: a practical approach to guideline directed management publication-title: Lancet – volume: 143 start-page: 120 year: 2021 end-page: 134 ident: bib29 article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction publication-title: Circulation – volume: 55 year: 2021 ident: bib35 article-title: Genetics of myocardial interstitial fibrosis in the human heart and association with disease publication-title: medRxiv – volume: 21 start-page: 553 year: 2019 end-page: 576 ident: bib38 article-title: Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology publication-title: Eur. J. Heart Fail. – volume: 40 start-page: 527 year: 2022 end-page: 538 ident: bib32 article-title: Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data publication-title: Nat. Biotechnol. – volume: 92 start-page: 785 year: 1995 end-page: 789 ident: bib4 article-title: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study publication-title: Circulation – volume: 43 start-page: e47 year: 2015 ident: bib16 article-title: Limma powers differential expression analyses for RNA-sequencing and microarray studies publication-title: Nucleic Acids Res. – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: bib22 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl. Acad. Sci. USA – volume: 28 start-page: 27 year: 2000 end-page: 30 ident: bib23 article-title: KEGG: kyoto encyclopedia of genes and genomes publication-title: Nucleic Acids Res. – volume: 123 start-page: 29 year: 2012 end-page: 37 ident: bib46 article-title: Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7) publication-title: Clin Sci – volume: 324 start-page: 488 year: 2020 end-page: 504 ident: bib6 article-title: Heart failure with reduced ejection fraction: a review publication-title: JAMA, J. Am. Med. Assoc. – volume: 12 start-page: 453 year: 2015 end-page: 457 ident: bib30 article-title: Robust enumeration of cell subsets from tissue expression profiles publication-title: Nat. Methods – volume: 143 start-page: 120 year: 2021 end-page: 134 ident: bib10 article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction publication-title: Circulation – volume: 14 start-page: 1338 year: 2021 end-page: 1350 ident: bib49 article-title: Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes publication-title: JACC Cardiovasc Imaging – volume: 12 start-page: 77 year: 2011 ident: bib27 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinf. – volume: 111 start-page: 18 year: 2019 end-page: 25 ident: bib56 article-title: Atrial and brain natriuretic peptides: hormones secreted from the heart publication-title: Peptides (N.Y.) – volume: 21 start-page: 3940 year: 2005 end-page: 3941 ident: bib28 article-title: ROCR: visualizing classifier performance in R publication-title: Bioinformatics – volume: 5 start-page: 716 year: 2018 end-page: 723 ident: bib40 article-title: Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy publication-title: ESC Heart Fail – volume: 608 start-page: 174 year: 2022 end-page: 180 ident: bib18 article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy publication-title: Nature – volume: 118 start-page: 1021 year: 2016 end-page: 1040 ident: bib52 article-title: Cardiac fibrosis: the fibroblast awakens publication-title: Circ. Res. – volume: 8 start-page: 406 year: 2023 end-page: 418 ident: bib44 article-title: Clustering of cardiac transcriptome profiles reveals unique: subgroups of dilated cardiomyopathy patients publication-title: JACC Basic Transl Sci – volume: 155 year: 2023 ident: bib13 article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities publication-title: J. Gen. Physiol. – volume: 7 start-page: 1161 year: 2022 end-page: 1179 ident: bib50 article-title: Inefficient batteries in heart failure: metabolic bottlenecks disrupting the mitochondrial ecosystem publication-title: JACC Basic Transl Sci – volume: 121 start-page: 722 year: 2017 end-page: 730 ident: bib5 article-title: Classification, epidemiology, and global burden of cardiomyopathies publication-title: Circ. Res. – volume: 12 start-page: 1 year: 2021 end-page: 20 ident: bib33 article-title: Inference and analysis of cell-cell communication using CellChat publication-title: Nat. Commun. – volume: 11 year: 2010 ident: bib21 article-title: A flexible R package for nonnegative matrix factorization publication-title: BMC Bioinf. – volume: 56 start-page: 1166 year: 2010 end-page: 1176 ident: bib62 article-title: Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases publication-title: Clin. Chem. – volume: 11 start-page: 1 year: 2022 end-page: 15 ident: bib61 article-title: Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure publication-title: Biology – volume: 23 year: 2022 ident: bib17 article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy publication-title: Int. J. Mol. Sci. – volume: 23 year: 2022 ident: bib11 article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy publication-title: Int. J. Mol. Sci. – volume: 130 start-page: 170 year: 2019 end-page: 183 ident: bib36 article-title: Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy publication-title: J. Mol. Cell. Cardiol. – volume: 371 start-page: 993 year: 2014 end-page: 1004 ident: bib55 article-title: Angiotensin–neprilysin inhibition versus enalapril in heart failure publication-title: N. Engl. J. Med. – volume: 4 start-page: 114 year: 2011 end-page: 120 ident: bib59 article-title: Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide publication-title: Circ Heart Fail – volume: 33 start-page: 2938 year: 2017 end-page: 2940 ident: bib26 article-title: UpSetR: an R package for the visualization of intersecting sets and their properties publication-title: Bioinformatics – year: 2022 ident: bib42 article-title: Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy publication-title: Heart – volume: 3 start-page: 207 year: 2010 end-page: 211 ident: bib58 article-title: Plasma Soluble Corin in patients with heart failure publication-title: Circ Heart Fail – volume: 238 year: 2022 ident: bib7 article-title: Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines publication-title: Pharmacol. Ther. – volume: 18 start-page: 1 year: 2020 end-page: 16 ident: bib19 article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression publication-title: BMC Med. – volume: 18 start-page: 1 year: 2020 end-page: 16 ident: bib9 article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression publication-title: BMC Med. – volume: 21 year: 2020 ident: bib64 article-title: Cardiac-specific overexpression of catalytically inactive corin reduces edema, contractile dysfunction, and death in mice with dilated cardiomyopathy publication-title: Int. J. Mol. Sci. – volume: 23 start-page: 1846 year: 2007 end-page: 1847 ident: bib15 article-title: GEOquery: a bridge between the gene expression Omnibus (GEO) and BioConductor publication-title: Bioinformatics – volume: 13 start-page: 1 year: 2022 end-page: 10 ident: bib53 article-title: MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis publication-title: Cell Death Dis. – volume: 95 start-page: 1354 year: 2020 end-page: 1368 ident: bib8 article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19 publication-title: Mayo Clin. Proc. – volume: 40 start-page: 245 year: 2022 end-page: 253 ident: bib31 article-title: Differential abundance testing on single-cell data using k-nearest neighbor graphs publication-title: Nat. Biotechnol. – year: 2015 ident: bib39 article-title: Hypertrophic Cardiomyopathy in Adulthood Associated with Low Cardiovascular Mortality with Contemporary Management Strategies – volume: 79 start-page: 2219 year: 2022 end-page: 2232 ident: bib43 article-title: Precision phenotyping of dilated cardiomyopathy using multidimensional data publication-title: J. Am. Coll. Cardiol. – volume: 155 year: 2023 ident: bib34 article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities publication-title: J. Gen. Physiol. – volume: 95 start-page: 1354 year: 2020 end-page: 1368 ident: bib47 article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19 publication-title: Mayo Clin. Proc. – volume: 2 year: 2021 ident: bib24 article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data publication-title: Innovation – volume: 97 start-page: 8525 year: 2000 end-page: 8529 ident: bib57 article-title: Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme publication-title: Proc Natl Acad Sci U S A – volume: 116 start-page: 806 year: 2020 end-page: 816 ident: bib51 article-title: Coronary microvascular dysfunction in hypertrophy and heart failure publication-title: Cardiovasc. Res. – volume: 608 start-page: 174 year: 2022 end-page: 180 ident: bib12 article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy publication-title: Nature – volume: 402 year: 2021 ident: bib37 article-title: Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis publication-title: Exp. Cell Res. – volume: 5 year: 2020 ident: bib14 article-title: Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy publication-title: JCI Insight – volume: 11 start-page: 1 year: 2021 end-page: 19 ident: bib45 article-title: Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy publication-title: Sci. Rep. – volume: 9 year: 2008 ident: bib25 article-title: WGCNA: an R package for weighted correlation network analysis publication-title: BMC Bioinf. – volume: 144 start-page: 759 year: 2021 end-page: 762 ident: bib3 article-title: Myosin modulation in hypertrophic cardiomyopathy and systolic heart failure: getting inside the engine publication-title: Circulation – volume: 9 year: 2023 ident: bib48 article-title: Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics publication-title: Cell Discov – volume: 123 start-page: 1285 year: 2018 end-page: 1297 ident: bib54 article-title: Myofibroblast-specific TGFβ receptor II signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy publication-title: Circ. Res. – volume: 286 start-page: 362 year: 2019 end-page: 372 ident: bib2 article-title: Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature publication-title: J. Intern. Med. – volume: 61 start-page: 327 year: 2013 end-page: 332 ident: bib63 article-title: Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy publication-title: Hypertension – volume: 348 start-page: 295 year: 2003 end-page: 303 ident: bib41 article-title: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy publication-title: N. Engl. J. Med. – volume: 67 start-page: 362 year: 2016 end-page: 367 ident: bib60 article-title: Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-type natriuretic peptide and heart failure development publication-title: Hypertension – volume: 48 start-page: D498 year: 2020 end-page: D503 ident: bib20 article-title: The reactome pathway knowledgebase publication-title: Nucleic Acids Res. – volume: 608 start-page: 174 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib18 article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy publication-title: Nature doi: 10.1038/s41586-022-04817-8 – volume: 9 year: 2023 ident: 10.1016/j.heliyon.2024.e37838_bib48 article-title: Lineage-specific regulatory changes in hypertrophic cardiomyopathy unraveled by single-nucleus RNA-seq and spatial transcriptomics publication-title: Cell Discov doi: 10.1038/s41421-022-00490-3 – volume: 116 start-page: 806 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib51 article-title: Coronary microvascular dysfunction in hypertrophy and heart failure publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvaa023 – volume: 111 start-page: 18 year: 2019 ident: 10.1016/j.heliyon.2024.e37838_bib56 article-title: Atrial and brain natriuretic peptides: hormones secreted from the heart publication-title: Peptides (N.Y.) doi: 10.1016/j.peptides.2018.05.012 – volume: 5 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib14 article-title: Effects of MYBPC3 loss-of-function mutations preceding hypertrophic cardiomyopathy publication-title: JCI Insight doi: 10.1172/jci.insight.133782 – volume: 8 start-page: 406 year: 2023 ident: 10.1016/j.heliyon.2024.e37838_bib44 article-title: Clustering of cardiac transcriptome profiles reveals unique: subgroups of dilated cardiomyopathy patients publication-title: JACC Basic Transl Sci doi: 10.1016/j.jacbts.2022.10.010 – volume: 608 start-page: 174 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib12 article-title: Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy publication-title: Nature doi: 10.1038/s41586-022-04817-8 – volume: 23 start-page: 1846 year: 2007 ident: 10.1016/j.heliyon.2024.e37838_bib15 article-title: GEOquery: a bridge between the gene expression Omnibus (GEO) and BioConductor publication-title: Bioinformatics doi: 10.1093/bioinformatics/btm254 – volume: 286 start-page: 362 year: 2019 ident: 10.1016/j.heliyon.2024.e37838_bib2 article-title: Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: a translational review of current literature publication-title: J. Intern. Med. doi: 10.1111/joim.12944 – volume: 11 start-page: 1 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib45 article-title: Differences in molecular phenotype in mouse and human hypertrophic cardiomyopathy publication-title: Sci. Rep. doi: 10.1038/s41598-021-89451-6 – volume: 348 start-page: 295 year: 2003 ident: 10.1016/j.heliyon.2024.e37838_bib41 article-title: Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa021332 – volume: 67 start-page: 362 year: 2016 ident: 10.1016/j.heliyon.2024.e37838_bib60 article-title: Depressed corin levels indicate early systolic dysfunction before increases of atrial natriuretic peptide/B-type natriuretic peptide and heart failure development publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.115.06300 – volume: 95 start-page: 1354 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib47 article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19 publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2020.04.028 – volume: 9 year: 2008 ident: 10.1016/j.heliyon.2024.e37838_bib25 article-title: WGCNA: an R package for weighted correlation network analysis publication-title: BMC Bioinf. doi: 10.1186/1471-2105-9-559 – volume: 371 start-page: 993 year: 2014 ident: 10.1016/j.heliyon.2024.e37838_bib55 article-title: Angiotensin–neprilysin inhibition versus enalapril in heart failure publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1409077 – volume: 43 start-page: e47 year: 2015 ident: 10.1016/j.heliyon.2024.e37838_bib16 article-title: Limma powers differential expression analyses for RNA-sequencing and microarray studies publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv007 – volume: 23 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib17 article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23020946 – volume: 14 start-page: 1338 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib49 article-title: Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes publication-title: JACC Cardiovasc Imaging doi: 10.1016/j.jcmg.2020.11.006 – volume: 118 start-page: 1021 year: 2016 ident: 10.1016/j.heliyon.2024.e37838_bib52 article-title: Cardiac fibrosis: the fibroblast awakens publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.115.306565 – volume: 21 start-page: 3940 year: 2005 ident: 10.1016/j.heliyon.2024.e37838_bib28 article-title: ROCR: visualizing classifier performance in R publication-title: Bioinformatics doi: 10.1093/bioinformatics/bti623 – volume: 12 start-page: 453 year: 2015 ident: 10.1016/j.heliyon.2024.e37838_bib30 article-title: Robust enumeration of cell subsets from tissue expression profiles publication-title: Nat. Methods doi: 10.1038/nmeth.3337 – volume: 102 start-page: 15545 year: 2005 ident: 10.1016/j.heliyon.2024.e37838_bib22 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 130 start-page: 170 year: 2019 ident: 10.1016/j.heliyon.2024.e37838_bib36 article-title: Activation of the PP2A catalytic subunit by ivabradine attenuates the development of diabetic cardiomyopathy publication-title: J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2019.04.011 – volume: 12 start-page: 1 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib33 article-title: Inference and analysis of cell-cell communication using CellChat publication-title: Nat. Commun. doi: 10.1038/s41467-021-21246-9 – volume: 11 year: 2010 ident: 10.1016/j.heliyon.2024.e37838_bib21 article-title: A flexible R package for nonnegative matrix factorization publication-title: BMC Bioinf. doi: 10.1186/1471-2105-11-367 – volume: 61 start-page: 327 year: 2013 ident: 10.1016/j.heliyon.2024.e37838_bib63 article-title: Corin overexpression improves cardiac function, heart failure, and survival in mice with dilated cardiomyopathy publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.112.193631 – year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib42 article-title: Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy publication-title: Heart doi: 10.1136/heartjnl-2021-320729 – volume: 402 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib37 article-title: Mitoferrin 2 deficiency prevents mitochondrial iron overload-induced endothelial injury and alleviates atherosclerosis publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2021.112552 – volume: 18 start-page: 1 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib19 article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression publication-title: BMC Med. doi: 10.1186/s12916-019-1469-4 – volume: 398 start-page: 2102 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib1 article-title: Hypertrophic cardiomyopathy: a practical approach to guideline directed management publication-title: Lancet doi: 10.1016/S0140-6736(21)01205-8 – volume: 97 start-page: 8525 year: 2000 ident: 10.1016/j.heliyon.2024.e37838_bib57 article-title: Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.150149097 – volume: 56 start-page: 1166 year: 2010 ident: 10.1016/j.heliyon.2024.e37838_bib62 article-title: Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases publication-title: Clin. Chem. doi: 10.1373/clinchem.2010.143883 – volume: 7 start-page: 1161 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib50 article-title: Inefficient batteries in heart failure: metabolic bottlenecks disrupting the mitochondrial ecosystem publication-title: JACC Basic Transl Sci doi: 10.1016/j.jacbts.2022.03.017 – volume: 55 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib35 article-title: Genetics of myocardial interstitial fibrosis in the human heart and association with disease publication-title: medRxiv – volume: 48 start-page: D498 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib20 article-title: The reactome pathway knowledgebase publication-title: Nucleic Acids Res. – volume: 95 start-page: 1354 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib8 article-title: Marked up-regulation of ACE2 in hearts of patients with obstructive hypertrophic cardiomyopathy: implications for SARS-CoV-2–mediated COVID-19 publication-title: Mayo Clin. Proc. doi: 10.1016/j.mayocp.2020.04.028 – volume: 13 start-page: 1 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib53 article-title: MYBPC3 deficiency in cardiac fibroblasts drives their activation and contributes to fibrosis publication-title: Cell Death Dis. doi: 10.1038/s41419-022-05403-6 – volume: 238 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib7 article-title: Recent advances in the pharmacological therapy of chronic heart failure: evidence and guidelines publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2022.108185 – volume: 123 start-page: 29 year: 2012 ident: 10.1016/j.heliyon.2024.e37838_bib46 article-title: Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7) publication-title: Clin Sci doi: 10.1042/CS20110403 – volume: 144 start-page: 759 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib3 article-title: Myosin modulation in hypertrophic cardiomyopathy and systolic heart failure: getting inside the engine publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.121.056324 – volume: 123 start-page: 1285 year: 2018 ident: 10.1016/j.heliyon.2024.e37838_bib54 article-title: Myofibroblast-specific TGFβ receptor II signaling in the fibrotic response to cardiac myosin binding protein C-induced cardiomyopathy publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.118.313089 – volume: 143 start-page: 120 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib10 article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.050498 – volume: 4 start-page: 114 year: 2011 ident: 10.1016/j.heliyon.2024.e37838_bib59 article-title: Decompensated heart failure is associated with reduced corin levels and decreased cleavage of pro-atrial natriuretic peptide publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.109.895581 – volume: 155 year: 2023 ident: 10.1016/j.heliyon.2024.e37838_bib34 article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities publication-title: J. Gen. Physiol. doi: 10.1085/jgp.202213204 – volume: 3 start-page: 207 year: 2010 ident: 10.1016/j.heliyon.2024.e37838_bib58 article-title: Plasma Soluble Corin in patients with heart failure publication-title: Circ Heart Fail doi: 10.1161/CIRCHEARTFAILURE.109.903849 – volume: 2 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib24 article-title: clusterProfiler 4.0: a universal enrichment tool for interpreting omics data publication-title: Innovation – volume: 5 start-page: 716 year: 2018 ident: 10.1016/j.heliyon.2024.e37838_bib40 article-title: Homozygous missense MYBPC3 Pro873His mutation associated with increased risk for heart failure development in hypertrophic cardiomyopathy publication-title: ESC Heart Fail doi: 10.1002/ehf2.12288 – volume: 11 start-page: 1 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib61 article-title: Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure publication-title: Biology – volume: 12 start-page: 77 year: 2011 ident: 10.1016/j.heliyon.2024.e37838_bib27 article-title: pROC: an open-source package for R and S+ to analyze and compare ROC curves publication-title: BMC Bioinf. doi: 10.1186/1471-2105-12-77 – volume: 143 start-page: 120 year: 2021 ident: 10.1016/j.heliyon.2024.e37838_bib29 article-title: Myocardial gene expression signatures in human heart failure with preserved ejection fraction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.120.050498 – volume: 23 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib11 article-title: Common and distinctive intercellular communication patterns in human obstructive and nonobstructive hypertrophic cardiomyopathy publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms23020946 – volume: 155 year: 2023 ident: 10.1016/j.heliyon.2024.e37838_bib13 article-title: cMyBP-C ablation in human engineered cardiac tissue causes progressive Ca2+-handling abnormalities publication-title: J. Gen. Physiol. doi: 10.1085/jgp.202213204 – volume: 21 start-page: 553 year: 2019 ident: 10.1016/j.heliyon.2024.e37838_bib38 article-title: Heart failure in cardiomyopathies: a position paper from the heart failure association of the European society of cardiology publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.1461 – volume: 324 start-page: 488 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib6 article-title: Heart failure with reduced ejection fraction: a review publication-title: JAMA, J. Am. Med. Assoc. doi: 10.1001/jama.2020.10262 – volume: 33 start-page: 2938 year: 2017 ident: 10.1016/j.heliyon.2024.e37838_bib26 article-title: UpSetR: an R package for the visualization of intersecting sets and their properties publication-title: Bioinformatics doi: 10.1093/bioinformatics/btx364 – volume: 40 start-page: 245 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib31 article-title: Differential abundance testing on single-cell data using k-nearest neighbor graphs publication-title: Nat. Biotechnol. doi: 10.1038/s41587-021-01033-z – volume: 40 start-page: 527 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib32 article-title: Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data publication-title: Nat. Biotechnol. doi: 10.1038/s41587-021-01091-3 – volume: 28 start-page: 27 year: 2000 ident: 10.1016/j.heliyon.2024.e37838_bib23 article-title: KEGG: kyoto encyclopedia of genes and genomes publication-title: Nucleic Acids Res. doi: 10.1093/nar/28.1.27 – volume: 121 start-page: 722 year: 2017 ident: 10.1016/j.heliyon.2024.e37838_bib5 article-title: Classification, epidemiology, and global burden of cardiomyopathies publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.117.309711 – volume: 79 start-page: 2219 year: 2022 ident: 10.1016/j.heliyon.2024.e37838_bib43 article-title: Precision phenotyping of dilated cardiomyopathy using multidimensional data publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2022.03.375 – volume: 21 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib64 article-title: Cardiac-specific overexpression of catalytically inactive corin reduces edema, contractile dysfunction, and death in mice with dilated cardiomyopathy publication-title: Int. J. Mol. Sci. – volume: 92 start-page: 785 year: 1995 ident: 10.1016/j.heliyon.2024.e37838_bib4 article-title: Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study publication-title: Circulation doi: 10.1161/01.CIR.92.4.785 – volume: 18 start-page: 1 year: 2020 ident: 10.1016/j.heliyon.2024.e37838_bib9 article-title: Multi-level transcriptome sequencing identifies COL1A1 as a candidate marker in human heart failure progression publication-title: BMC Med. doi: 10.1186/s12916-019-1469-4 – year: 2015 ident: 10.1016/j.heliyon.2024.e37838_bib39 |
SSID | ssj0001586973 |
Score | 2.2837553 |
Snippet | Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | e37838 |
SubjectTerms | algorithms Bioinformatics biomarkers Cardiomyopathy CORIN fibroblasts fibrosis heart failure Heart failure with reduced ejection fraction microarray technology Molecular subtypes myocardium patients prognosis rats RNA sequence analysis therapeutics |
Title | Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course |
URI | https://dx.doi.org/10.1016/j.heliyon.2024.e37838 https://www.ncbi.nlm.nih.gov/pubmed/39315128 https://www.proquest.com/docview/3108765796 https://www.proquest.com/docview/3154159982 https://pubmed.ncbi.nlm.nih.gov/PMC11417248 https://doaj.org/article/80e67d742be24dd78cfed6df9dd150c2 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gLouVrKUVG4pptGju2w61UVAWJghCVerP8MVazKknVpof998zE2bILEr1w3U029sx450385pmxd8kJEUINReO8KqSOuKQwqxTeS6kNaaDByLY4VSdn8vN5fb521BdxwrI8cDbcvilB6YgFnIdKxqhNSBBVTE2MiGXC-O-LOW-tmMr9wUY1Wvxu2dlfzC_gsl32pHlayTkIbagnZS0ZjZr9Gznpb8z5J3VyLRcdP2GPJxDJD_Pgt9kD6HbYwy_TNvlT1n4j1lVW3ODUQMLDSDv9uezpBOIlH3pOJ1kPPLmWeOmcXsfya5JxhchhMfKz6Nbc9vCeH_Kjr98_nfIIpDiBo-KhJ_rHM3Z2_PHH0UkxnalQBEQuQ1EFoTAtOieFco32QmkZ6-RxWRpxgA5t9EFCFKaFMtqZKqLtyzL4pkxofg_iOdvq-g5eMp6iU75xWDIhiClr4xKUlXMgjQoBgp-x-cq49ipLZ9gVp2xhJ29Y8obN3pixD-SCu4tJ-Xr8AOPBTvFg74uHGTMrB9oJRGRwgD_V3vf8tyuHW1xktHPiOuhvbyxiYIxaatv91zU1giGsXnEIL3KQ3M1ENIKQFT7BbITPxlQ3v-nai1HsG-tVxJjSvPofxtllj2i-me_ymm0N17ewh6Bq8G_G9fMLOiclNA |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Progression+from+cardiomyopathy+to+heart+failure+with+reduced+ejection+fraction%3A+A+CORIN+deficient+course&rft.jtitle=Heliyon&rft.au=Kan%2C+Jun-yan&rft.au=Wang%2C+Dong-chen&rft.au=Jiang%2C+Zi-hao&rft.au=Wu%2C+Li-da&rft.date=2024-09-30&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=10&rft.issue=18+p.e37838-&rft_id=info:doi/10.1016%2Fj.heliyon.2024.e37838&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon |